Clinical trials
Leukemia, Myelomonocytic, Chronic trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Astex Pharmaceuticals, Inc. | 1 |
| Blueprint Medicines Corporation | 1 |
| Cogent Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Hemavant Sciences GmbH | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelomonocytic, Chronic | 20 |
| Myelodysplastic Syndromes | 14 |
| Leukemia, Myeloid, Acute | 11 |
| Myeloproliferative Disorders | 7 |
| Leukemia | 6 |
| Anemia, Refractory, with Excess of Blasts | 5 |
| Neoplasms | 5 |
| Polycythemia Vera | 5 |
| Primary Myelofibrosis | 5 |
| Thrombocythemia, Essential | 5 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.